Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases

Table 5

Multivariate competing risk analysis for graft survival.

	Death with retransplantation as competing risk			Retransplantation with competing risk of death
	SHR	95% CI	value	SHR	95% CI	value
Age	1.02	1.02–1.03	<0.001	0.95	0.95–0.96	<0.001
Gender	1.18	1.06–1.31	0.002	1.06	0.90–1.24	0.475
BMI at transplant	1	1.02–1.34	0.024	1	0.98–1	0.824
MELD at transplant	1	1–1	0.001	0.99	0.98–1	0.301
Cold ischemia (hours)	1.02	1–1	<0.001	1.02	1–1.04	0.002
Donor age	1	1–1	0.002	1.01	1.01–1.02	<0.001
ABO match
Identical	Ref
Compatible	0.99	0.82–1.2	0.968	1.16	0.89–1.51	0.256
Incompatible	1.08	0.62–1.88	0.782	0.56	0.17–1.81	0.337
Diagnostic
AIH	Ref
PBC	0.77	0.68–0.88	<0.001	1.04	0.81–1.34	0.723
PSC	0.69	0.61–0.79	<0.001	1.32	1.09–1.61	0.005
African Americans	1.16	1.02–1.34	0.024	0.97	0.81–1.17	0.824

BMI, body mass index. AIH, autoimmune hepatitis. PBC, primary biliary cholangitis. PSC, primary sclerosing cholangitis. MELD, model for end-stage liver disease. SHR, subdistribution hazard ratio. CI, confidence interval. REF, reference.